Genes in Focus
The biobank is returning results for 7 pharmacogenetic (PGx) genes: CYP2C19, SLCO1B1, DPYD, CYP2C9, TPMT, NUDT15, and ABCG2.
Pharmacogenetic Results
Results that may predict response to medications. Information for healthcare professionals.
Overview of Pharmacogenetic Return of Results
Pharmacogenetics (PGx) is the use of genetic information to help guide drug selection and dosing.
The Colorado Center for Personalized Medicine is enrolling participants in a research biobank, primarily focused on genetics.
Biobank participants may give permission to return available genetic test results, including select, clinically-actionable PGx test results to their UCHealth electronic health record (EHR).
Prerequisites for Return
In order for results to be available to providers, a biobank participant must have a blood or saliva sample collected and processed and sign appropriate consent for return.Click Here for FAQs
For immediate questions, send a secure chat message to Groups: "Pharmacogenomics Service" in UCHealth's EHRPGx Exceptions
Click here to learn how liver transplant & allogeneic BMT impact PGx results.
Drug-Gene Pairs
Pharmacogenetic Tip Sheets
Colorado Center for Personalized Medicine
University of Colorado Anschutz Medical Campus
CU Anschutz
Anschutz Health Sciences Building
1890 N Revere Ct
Mailstop F563
Aurora, CO 80045
CMS Login